{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:50:52Z","timestamp":1757541052617,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["3101"],"award-info":[{"award-number":["3101"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00284-020-01970-z","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T13:03:42Z","timestamp":1586955822000},"page":"1667-1672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran"],"prefix":"10.1007","volume":"77","author":[{"given":"Zainab","family":"Bandalizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-8436","authenticated-orcid":false,"given":"Tahereh","family":"Shokohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Moosazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Keikha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Seyedpor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Rabie Rudsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhang","family":"Babamahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Ghasemian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Mardani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Javanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Soleimanpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Asghar","family":"Sefidgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehran","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mehdi","family":"Gouya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedmojtaba","family":"Seyedmousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"issue":"8","key":"1970_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM et al (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17(8):873\u2013881","journal-title":"Lancet Infect Dis"},{"key":"1970_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00357-16","author":"KJ Kwon-Chung","year":"2017","unstructured":"Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR et al (2017) The case for adopting the \u201cSpecies Complex\u201d nomenclature for the etiologic agents of cryptococcosis. mSphere. https:\/\/doi.org\/10.1128\/mSphere.00357-16","journal-title":"mSphere"},{"issue":"2","key":"1970_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","volume":"14","author":"RC May","year":"2016","unstructured":"May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K (2016) Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol 14(2):106\u2013117","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"1970_CR4","first-page":"13","volume":"13","author":"PR Williamson","year":"2017","unstructured":"Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A et al (2017) Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Microbiol 13(1):13\u201324","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"1970_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1086\/368091","volume":"36","author":"SA Mirza","year":"2003","unstructured":"Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME et al (2003) The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000. Clin Infect Dis 36(6):789\u2013794","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1970_CR6","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/QAD.0b013e32832be0fc","volume":"23","author":"JN Jarvis","year":"2009","unstructured":"Jarvis JN, Boulle A, Loyse A, Bicanic T, Rebe K, Williams A et al (2009) High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS 23(9):1182\u20131183","journal-title":"AIDS"},{"key":"1970_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). https:\/\/doi.org\/10.3390\/jof3040057","journal-title":"J Fungi (Basel)"},{"issue":"7","key":"1970_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","volume":"16","author":"N French","year":"2002","unstructured":"French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M et al (2002) Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 16(7):1031\u20131038","journal-title":"AIDS"},{"issue":"7","key":"1970_CR9","doi-asserted-by":"publisher","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","volume":"8","author":"JN Jarvis","year":"2013","unstructured":"Jarvis JN, Harrison TS, Lawn SD, Meintjes G, Wood R, Cleary S (2013) Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. PLoS ONE 8(7):e69288. https:\/\/doi.org\/10.1371\/journal.pone.0069288","journal-title":"PLoS ONE"},{"issue":"5","key":"1970_CR10","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1097\/QAI.0b013e31824c837e","volume":"59","author":"R Rajasingham","year":"2012","unstructured":"Rajasingham R, Meya DB, Boulware DR (2012) Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care. J Acquir Immune Defic Syndr 59(5):e85\u2013e91","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1970_CR11","unstructured":"World Health Organization (2018). Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018: supplement to the 2016 consolidated guidelines of the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization. https:\/\/www.who.int\/iris\/handle\/10665\/260399. Accessed 9 March 2020"},{"key":"1970_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/cid\/cir379","volume":"53","author":"MD Lindsley","year":"2011","unstructured":"Lindsley MD, Mekha N, Baggett HC, Surinthong Y, Autthateinchai R, Sawatwong P, Harris JR, Park BJ, Chiller T, Balajee SA, Poonwan N (2011) Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 53:321\u2013325","journal-title":"Clin Infect Dis"},{"key":"1970_CR13","doi-asserted-by":"publisher","first-page":"19040","DOI":"10.7448\/IAS.17.1.19040","volume":"17","author":"KA Magambo","year":"2014","unstructured":"Magambo KA, Kalluvya SE, Kapoor SW, Seni J, Chofle AA, Fitzgerald DW et al (2014) Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania. J Int AIDS Soc 17:19040","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"1970_CR14","first-page":"119","volume":"9","author":"M Hajiabdolbaghi","year":"2017","unstructured":"Hajiabdolbaghi M, Kalantari S, Jamshidi-Makiani M, Shojaei E, Abbasian L, Rasoulinezhad M et al (2017) Prevalence of cryptococcal antigen positivity among HIV infected patient with CD4 cell count less than 100 of Imam Khomeini Hospital, Tehran, Iran. Iran J Microbiol 9(2):119\u2013121","journal-title":"Iran J Microbiol"},{"issue":"6","key":"1970_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/cid\/ciu937","volume":"60","author":"J McKenney","year":"2012","unstructured":"McKenney J, Bauman S, Neary B, Detels R, French A, Margolick J et al (2012) Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986. Clin Infect Dis 60(6):959\u2013965","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1970_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/tmi.12790","volume":"21","author":"JE Vidal","year":"2016","unstructured":"Vidal JE, Toniolo C, Paulino A, Colombo A, Anjos Martins M, Silva Meira C et al (2016) Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in S\u00e3o Paulo, Brazil. Trop Med Int Health 21(12):1539\u20131544","journal-title":"Trop Med Int Health"},{"key":"1970_CR17","doi-asserted-by":"publisher","first-page":"18821","DOI":"10.7448\/IAS.17.1.18821","volume":"17","author":"AR Ganiem","year":"2014","unstructured":"Ganiem AR, Indrati AR, Wisaksana R, Meijerink H, Ven A, Alisjahbana B et al (2014) Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia. J Int AIDS Soc 17:18821. https:\/\/doi.org\/10.7448\/IAS.17.1.18821","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"1970_CR18","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1128\/JCM.01683-14","volume":"52","author":"A Lourens","year":"2014","unstructured":"Lourens A, Jarvis JN, Meintjes G, Samuel CM (2014) Rapid diagnosis of cryptococcal meningitis by use of lateral flow assay on cerebrospinal fluid samples: influence of the high-dose \u201chook\u201d effect. J Clin Microbiol 52(12):4172\u20134175","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1970_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/tmi.12067","volume":"18","author":"AC Meyer","year":"2013","unstructured":"Meyer AC, Kendi CK, Penner JA, Odhiambo N, Otieno B, Omondi E et al (2013) The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya. Trop Med Int Health 18(4):495\u2013503","journal-title":"Trop Med Int Health"},{"issue":"3","key":"1970_CR20","doi-asserted-by":"publisher","first-page":"e58377","DOI":"10.1371\/journal.pone.0058377","volume":"8","author":"AS Alemu","year":"2013","unstructured":"Alemu AS, Kempker RR, Tenna A, Smitson C, Berhe N, Fekade D et al (2013) High prevalence of cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia. PLoS ONE 8(3):e58377. https:\/\/doi.org\/10.1371\/journal.pone.0058377","journal-title":"PLoS ONE"},{"issue":"8","key":"1970_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","volume":"12","author":"CA Liechty","year":"2007","unstructured":"Liechty CA, Solberg P, Were W, Ekwaru JP, Ransom RL, Weidle PJ et al (2007) Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health 12(8):929\u2013935","journal-title":"Trop Med Int Health"},{"issue":"10","key":"1970_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/myc.12969","volume":"62","author":"E Karaman","year":"2019","unstructured":"Karaman E, Ilkit M, Ku\u015f\u00e7u F (2019) Identification of Cryptococcus antigen in HIV-positive Turkish patients by using the Dynamiker\u00ae lateral flow assay. Mycoses 62(10):961\u2013968","journal-title":"Mycoses"},{"issue":"4","key":"1970_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1086\/655143","volume":"51","author":"DB Meya","year":"2010","unstructured":"Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A et al (2010) Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count %3c or = 100 cells\/microL who start HIV therapy in resource-limited settings. Clin Infect Dis 51(4):448\u2013455","journal-title":"Clin Infect Dis"},{"issue":"27","key":"1970_CR24","first-page":"585","volume":"63","author":"J McKenney","year":"2014","unstructured":"McKenney J, Smith RM, Chiller TM, Detels R, French A, Margolick J et al (2014) Prevalence and correlates of cryptococcal antigen positivity among AIDS patients\u2014United States, 1986\u20132012. Morb Mortal Wkly Rep 63(27):585\u2013587","journal-title":"Morb Mortal Wkly Rep"},{"issue":"5","key":"1970_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cid\/civ936","volume":"62","author":"N Longley","year":"2016","unstructured":"Longley N, Jarvis JN, Meintjes G, Boulle A, Cross A, Kelly N et al (2016) Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study. Clin Infect Dis 62(5):581\u2013587","journal-title":"Clin Infect Dis"},{"key":"1970_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3855\/jidc.10476","volume":"12","author":"M Hedayati","year":"2018","unstructured":"Hedayati M, Tagizadeh Armaki M, Yazdani Charati J, Hedayati N, Seyedmousavi S, Denning D (2018) Burden of fungal infections in Iran. J Infect Dev Ctries 12:910\u2013918","journal-title":"J Infect Dev Ctries"},{"key":"1970_CR27","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001101","author":"Z Bandalizadeh","year":"2020","unstructured":"Bandalizadeh Z, Shokohi T, Badali H, Abastabar M, Babamahmoudi F, Davoodi L et al (2020) Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans\/Cryptococcus gattii species complex. J Med Microbiol. https:\/\/doi.org\/10.1099\/jmm.0.001101","journal-title":"J Med Microbiol"},{"issue":"1","key":"1970_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12879-017-2325-9","volume":"17","author":"A Ramachandran","year":"2017","unstructured":"Ramachandran A, Manabe Y, Rajasingham R, Shah M (2017) Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda. BMC Infect Dis 17(1):225. https:\/\/doi.org\/10.1186\/s12879-017-2325-9","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1970_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/cid\/ciy567","volume":"68","author":"E Temfack","year":"2019","unstructured":"Temfack E, Bigna JJ, Luma HN, Spijker R, Meintjes G, Jarvis JN et al (2019) Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in antiretroviral-naive human immunodeficiency virus-infected adults with CD4 Cell counts <100\/\u03bcL: a systematic review and metaanalysis. Clin Infect Dis 68(4):688\u2013698","journal-title":"Clin Infect Dis"},{"key":"1970_CR30","unstructured":"National Institutes of Health (2013) AIDSinfo Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. www.aidsinfo.nih.gov. Accessed 9 March 2020"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-01970-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-020-01970-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-020-01970-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T08:00:48Z","timestamp":1618473648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-020-01970-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s00284-020-01970-z","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"type":"print","value":"0343-8651"},{"type":"electronic","value":"1432-0991"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"25 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Seyedmojtaba Seyedmousavi was supported by the\u00a0Intramural\u00a0Research Program of the National Institutes of Health, Clinical Center, Department of Laboratory Medicine.\u00a0The authors declare no conflicts of interest related to this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee of Mazandaran University of Medical Sciences, Sari, Iran (IR.MAZUMS.REC. 1396.3101), and it has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants or their legally authorized representatives gave informed consent. The data collected were considered and presented in secret manner.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}